Atrial Septal Defect Global Market Report 2024

Description

An atrial septal defect (ASD) is a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, leading to increased blood flow to the lungs and potential complications such as pulmonary hypertension and heart failure over time.

The main treatment options for atrial septal defects include surgical closure, transcatheter closure, hybrid procedures, and medication therapy. Surgical closure involves repairing or sealing the abnormal opening through surgical intervention. Diagnostic techniques used for ASD include chest x-rays, electrocardiograms, cardiac catheterization, transesophageal echocardiography, and pulse oximetry. These diagnostics are facilitated by medical devices and pharmaceutical products and are utilized in pediatric and adult patients across various healthcare settings, including hospitals, ambulatory surgical centers, cardiac clinics, and others.

The arterial septal defect research report is one of a series of new reports from The Business Research Company that provides arterial septal defect market statistics, including the arterial septal defect industry's global market size, regional shares, competitors with an arterial septal defect market share, detailed arterial septal defect market segments, market trends and opportunities, and any further data you may need to thrive in the arterial septal defect industry. This arterial septal defect market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The atrial septal defect market size has grown strongly in recent years. It will grow from $3.85 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth observed in the historic period can be attributed to several factors. These include the rise in the number of congenital heart disease cases, increased funding for research and development of treatments for atrial septal defects (ASD), high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries for ASD, approval of new ASD closure devices and therapies by regulatory bodies such as the FDA, and the expansion of healthcare facilities specializing in cardiac care.

The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $5.6 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. In the forecast period, growth can be attributed to several key factors. These include the increased utilization of telemedicine for pre and post-operative care in ASD cases, the growth of personalized treatment plans based on genetic and phenotypic data, the ongoing rise in global healthcare spending with a focus on emerging markets, the expanding elderly population leading to a higher incidence of congenital heart defects diagnosed later in life, international harmonization of medical device regulations enhancing global market access, and the implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends expected in this period include the development of new, minimally invasive ASD closure devices, the integration of AI and machine learning for enhanced diagnosis and personalized treatment planning, the introduction of biodegradable and bioresorbable materials in device manufacturing, the utilization of AI-driven tools for real-time monitoring and decision support during ASD procedures, and the adoption of remote monitoring technologies for tracking patient recovery and early detection of complications.

The atrial septal defect market is anticipated to grow due to the rising prevalence of congenital heart defects (CHD). These defects are structural abnormalities in the heart that exist from birth. Treating atrial septal defects is crucial for managing CHD by correcting abnormal blood flow between the heart's chambers, improving heart function, and reducing associated complications. For example, data from the Australian Institute of Health and Welfare in June 2024 revealed that around 65,000 individuals in Australia, including children and adults, live with congenital heart disease. Hospitalizations related to congenital heart disease accounted for about 5,900 cases in the 2020-21 period, with 79 deaths occurring in infants under one year old, representing 7.8% of all infant deaths. This data underscores the driving force behind the atrial septal defect market's growth.

Key players in the arterial septal defect market are focusing on developing advanced devices and obtaining approvals to expand their availability and applications. Device approval is essential for gaining official authorization or certification from regulatory bodies before manufacturing, selling, or using a device in specific markets or purposes. For instance, in March 2024, Occlutech GmbH announced the FDA's approval of their Occlutech ASD Occluder and Occlutech Pistol Pusher for treating atrial septal defects (ASD). This milestone approval allows Occlutech to commercialize their devices in the US through an exclusive partnership with B. Braun Interventional Systems. The Occlutech ASD Occluder, a self-expanding nitinol device, offers a lifelong solution for patients with confirmed defects, enhancing healthcare globally.

In February 2022, Boston Scientific Corporation acquired Baylis Medical Company Inc. for $1.75 billion. This acquisition expands Boston Scientific's product portfolios in electrophysiology and structural heart interventions with Baylis Medical's transseptal platforms, guidewires, and left heart access tools, including the VersaCross RF Wire designed for creating atrial septal defects.

Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC

North America was the largest region in the atrial septal defect market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atrial septal defect market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atrial septal defect (ASD) market consists of revenues earned by entities by provide services such as diagnosis and monitoring, medication management, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial septal defect (ASD) market also includes sales of septal occluder devices, cardiac MRI systems, and anticoagulant medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atrial Septal Defect Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atrial septal defect market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for atrial septal defect ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atrial septal defect market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Procedure: Surgical Closure; Transcatheter Closure; Hybrid Procedures; Medication Therapy
2) By Diagnosis: Chest X-Ray; Electrocardiogram; Cardiac Catheterization; Transesophageal Echocardiography; Pulse Oximetry
3) By Product Type: Medical Devices; Pharmaceutical Products
4) By Age Group: Pediatric; Adult
5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Other End-Users
Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers; Boston Scientific Corporation; Philips Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18788

1. Executive Summary

2. Atrial Septal Defect Market Characteristics

3. Atrial Septal Defect Market Trends And Strategies

4. Atrial Septal Defect Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Atrial Septal Defect Market Size and Growth

5.1. Global Atrial Septal Defect Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Atrial Septal Defect Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Atrial Septal Defect Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Atrial Septal Defect Market Segmentation

6.1. Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Surgical Closure
Transcatheter Closure
Hybrid Procedures
Medication Therapy
6.2. Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chest X-Ray
Electrocardiogram
Cardiac Catheterization
Transesophageal Echocardiography
Pulse Oximetry
6.3. Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medical Devices
Pharmaceutical Products
6.4. Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pediatric
Adult
6.5. Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Ambulatory Surgical Centers
Cardiac Clinics
Other End-Users

7. Atrial Septal Defect Market Regional And Country Analysis

7.1. Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Atrial Septal Defect Market

8.1. Asia-Pacific Atrial Septal Defect Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Atrial Septal Defect Market

9.1. China Atrial Septal Defect Market Overview
9.2. China Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Atrial Septal Defect Market

10.1. India Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Atrial Septal Defect Market

11.1. Japan Atrial Septal Defect Market Overview
11.2. Japan Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Atrial Septal Defect Market

12.1. Australia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Atrial Septal Defect Market

13.1. Indonesia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Atrial Septal Defect Market

14.1. South Korea Atrial Septal Defect Market Overview
14.2. South Korea Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Atrial Septal Defect Market

15.1. Western Europe Atrial Septal Defect Market Overview
15.2. Western Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Atrial Septal Defect Market

16.1. UK Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Atrial Septal Defect Market

17.1. Germany Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Atrial Septal Defect Market

18.1. France Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Atrial Septal Defect Market

19.1. Italy Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Atrial Septal Defect Market

20.1. Spain Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Atrial Septal Defect Market

21.1. Eastern Europe Atrial Septal Defect Market Overview
21.2. Eastern Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Atrial Septal Defect Market

22.1. Russia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Atrial Septal Defect Market

23.1. North America Atrial Septal Defect Market Overview
23.2. North America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Atrial Septal Defect Market

24.1. USA Atrial Septal Defect Market Overview
24.2. USA Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Atrial Septal Defect Market

25.1. Canada Atrial Septal Defect Market Overview
25.2. Canada Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Atrial Septal Defect Market

26.1. South America Atrial Septal Defect Market Overview
26.2. South America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Atrial Septal Defect Market

27.1. Brazil Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Atrial Septal Defect Market

28.1. Middle East Atrial Septal Defect Market Overview
28.2. Middle East Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Atrial Septal Defect Market

29.1. Africa Atrial Septal Defect Market Overview
29.2. Africa Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Atrial Septal Defect Market Competitive Landscape And Company Profiles

30.1. Atrial Septal Defect Market Competitive Landscape
30.2. Atrial Septal Defect Market Company Profiles
- 30.2.1. Abbott Laboratories
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Medtronic plc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Siemens Healthineers
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Boston Scientific Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Philips Healthcare
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Atrial Septal Defect Market Other Major And Innovative Companies

31.1. Edwards Lifesciences Corporation
31.2. W. L. Gore & Associates Inc.
31.3. St. Jude Medical LLC
31.4. Cook Medical
31.5. Lepu Medical Technology Co. Ltd.
31.6. MicroPort Scientific Corporation
31.7. Lifetech Scientific Corporation
31.8. Venus Medtech Hangzhou Inc
31.9. Occlutech Holding AG
31.10. Coherex Medical
31.11. Osypka AG
31.12. Arjo AB
31.13. Heart Medical Europe BV
31.14. AtriCure Inc.
31.15. Asklepion Pharmaceuticals LLC

32. Global Atrial Septal Defect Market Competitive Benchmarking

33. Global Atrial Septal Defect Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Atrial Septal Defect Market

35. Atrial Septal Defect Market Future Outlook and Potential Analysis

35.1 Atrial Septal Defect Market In 2028 - Countries Offering Most New Opportunities
35.2 Atrial Septal Defect Market In 2028 - Segments Offering Most New Opportunities
35.3 Atrial Septal Defect Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer